JurisdictionAlabamaTitle 20Food, Drugs and Cosmetics
Ch. 2ADarren Wesley “Ato” Hall Compassion Act
Art. 4Cultivation, Processing, and Dispensing of Medical Cannabis
(a)(1) A processor license authorizes all of the following:
a. The purchase or transfer of cannabis from a cultivator.
b. The processing of cannabis into medical cannabis which shall include properly packaging and labeling medical cannabis products, in accordance with this section.
c. The sale or transfer of medical cannabis to a dispensary.
(2)A processor license authorizes the processor to transfer medical cannabis only by means of a secure transporter.
(b)The commission shall issue no more than four processor licenses.
(c)(1) All medical cannabis products must be medical grade product, manufactured using documented good quality practices, and meet Good Manufacturing Practices, such that the product is shown to meet intended levels of purity and be reliably free of toxins and contamina
Free access — add to your briefcase to read the full text and ask questions with AI
(a)(1) A processor license authorizes all of the following:
a. The purchase or transfer of cannabis from a cultivator.
b. The processing of cannabis into medical cannabis which shall include properly packaging and labeling medical cannabis products, in accordance with this section.
c. The sale or transfer of medical cannabis to a dispensary.
(2) A processor license authorizes the processor to transfer medical cannabis only by means of a secure transporter.
(b) The commission shall issue no more than four processor licenses.
(c)(1) All medical cannabis products must be medical grade product, manufactured using documented good quality practices, and meet Good Manufacturing Practices, such that the product is shown to meet intended levels of purity and be reliably free of toxins and contaminants. Medical cannabis products may not contain any additives other than pharmaceutical grade excipients.
(2) The
commission
shall be responsible for enforcing Good Manufacturing Practices.
(d) Medical cannabis products may not be processed into a form that is attractive to or targets children, including all of the following which are prohibited:
(1) Any product bearing any resemblance to a cartoon character, fictional character whose target audience is children or youth, or pop culture figure.
(2) Any product bearing a reasonable resemblance to a product available for consumption as a commercially available candy.
(3) Any product whose design resembles, by any means, another object commonly recognized as appealing to, or intended for use by, children.
(4) Any product whose shape bears the likeness or contains characteristics of a realistic or fictional human, animal, or fruit, including artistic, caricature, or cartoon rendering.
(e) All of the following shall apply to all packages and labels of medical cannabis products:
(1) Labels, packages, and containers shall not be attractive to minors and may not contain any content that reasonably appears to target children, including toys, cartoon characters, and similar images. Packages shall be designed to minimize appeal to children and must contain a label that reads: “Keep out of reach of children.”
(2) All medical cannabis products must be packaged in child-resistant, tamper-evident containers.
(3) All medical cannabis product labels shall contain, at a minimum, the following information:
a. Lot and batch numbers.
b. A license identification number for the cultivator and a license identification number for the processor.
c. Cannabinoids content and potency.
d. The universal state symbol printed in color at least one-half inch by one-half inch in size.
(f) The commission shall establish one universal flavor for all gelatinous cube, cuboid, and lozenge medical cannabis products.
(g) The following statement shall be included on each label, if space permits, or as an insert within the package: “WARNING: This product may make you drowsy or dizzy. Do not drink alcohol with this product. Use care when operating a vehicle or other machinery. Taking this product with medication may lead to harmful side effects or complications. Consult your physician before taking this product with any medication. Women who are breastfeeding, pregnant, or plan to become pregnant should discuss medical cannabis use with their physicians.”
(h) Any advertisement and any package or label may not contain any false statement or statement that advertises health benefits or therapeutic benefits of medical cannabis.
(i) The commission may require the implementation of a digital image such as a QR Code for purposes of tracking medical cannabis products. The digital image must interface with the statewide seed-to-sale tracking system.
(j) The commission shall determine what information from the label shall be entered into the statewide seed-to-sale tracking system.